Trial intelligence / Profile preview

Ketodex Versus Opioid Based Anesthesia in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy

NCT07246447Active, not recruiting

Sponsor
Cairo University
Start
Nov 2025
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketamine and dexmedetomidine in class III obesity (2 arms), sponsored by Cairo University. Primary endpoint: Total nalbuphine consumption at 24 hours. Started Nov 2025; status: active, not recruiting.

02

Drugs

ketaminedexmedetomidine
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT07246447.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07246447.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call